Compare RCEL & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCEL | MCI |
|---|---|---|
| Founded | N/A | 1971 |
| Country | United States | United States |
| Employees | 226 | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.8M | 350.3M |
| IPO Year | 2018 | N/A |
| Metric | RCEL | MCI |
|---|---|---|
| Price | $10.97 | $18.90 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.88 | N/A |
| AVG Volume (30 Days) | ★ 265.5K | 47.7K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | ★ 27.20 | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | ★ $71,610,000.00 | N/A |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $49.82 | N/A |
| P/E Ratio | ★ N/A | $10.36 |
| Revenue Growth | ★ 11.45 | N/A |
| 52 Week Low | $3.22 | $16.21 |
| 52 Week High | $11.81 | $21.50 |
| Indicator | RCEL | MCI |
|---|---|---|
| Relative Strength Index (RSI) | 68.92 | N/A |
| Support Level | $3.64 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.58 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 85.52 | 0.00 |
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.